Abcuro, Inc., a clinical-stage biotechnology company developing therapies for the treatment of autoimmune diseases and cancer through precise modulation of cytotoxic T cells, today announced the ...

Abcuro Inc. has raised a $200 million Series C financing to fund late-stage development and support commercial launch ...

Sarah Sheldon, an engineering physicist from IBM, talks to Joe McEntee about the company’s efforts to open up the next frontier in quantum computing – and why the emerging quantum technology industry ...

Non-English generative AI models are far less accurate and useful than their English-based counterparts — sometimes dramatically so. Companies paying for them should know what they’re getting, and ...

Indian businesses are making significant strides in AI adoption, with 87 per cent of surveyed companies have advanced their ...

Explore Rigetti's growth strategy for 2025 with advancements in quantum computing, key partnerships, and a focus on reducing ...

Enterprises need to tie their generative AI and agentic development efforts to foundational IT principles. AI development ...

Somerville, Mass.-based Mass General Brigham and IBM have teamed up to develop an AI tool for health systems and community health centers.

The Dow is on track to close with a gain for the month, propelled by Apple and IBM. Among the three major indexes, the S&P 500 and the Nasdaq both ended Monday with a 0.4% gain for the month, while ...

Scattering takes place across the universe at large and miniscule scales. Billiard balls clank off each other in bars, the ...

Oppenheimer analyst Param Singh initiated coverage of IBM stock with an Outperform rating and a $320 price target.

Dubai Future Foundation (DFF) and IBM today at the World Governments Summit (WGS) 2025 signed an memorandum of understanding ...